Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
AAN, abate, accessibility, accompanyingManagement, acid, adolescence, adulthood, antibody, anticholinesterase, blockade, bulbar, capture, CDC, closure, comment, confirmatory, Connecticut, coprolalia, Cortex, coughing, CPP, crossover, daytime, deploy, distinguishable, DMF, domestic, DQSA, dramatic, echolalia, editor, elevated, equating, ethnic, experimental, familiar, family, Firdapse®at, Firdapse®available, Firdapse®for, Firdapse®in, Firdapse®may, Firdapse®pursuant, grey, grimacing, head, hub, hyperactivity, impulsivity, inattention, inflict, intrusive, jerking, judgement, landlord, long, magnetic, main, makeup, male, marker, maximum, Merrigan, misdiagnosed, molar, neurobehavioral, neurodevelopmental, Nevada, ofour, oneself, opt, partly, Paul, PBM, persist, POC, poking, posting, predominance, prolonged, punching, push, qualitative, questioned, ready, reenacted, repeating, resistance, rich, room, Sabril®that, Sanofi, searchable, shoulder, shrugging, simple, SMA, somnolence, squeaking, sterile, stored, survey, swear, teaching, temperature, tie, top, tradename, true, undergone, undiagnosed, unwilling, uttering, vendor, weighed
Filing tables
Filing exhibits
CPRX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our reports dated March 15, 2016, with respect to the financial statements and internal control over financial reporting included in the Annual Report of Catalyst Pharmaceuticals, Inc. on Form 10-K for the year ended December 31, 2015. We consent to the incorporation by reference of said reports in the Registration Statements of Catalyst Pharmaceuticals, Inc. on Form S-3 as Post-Effective Amendment No. 6 to Form S-1 (File No. 333-180617), Forms S-8 (File No. 333-151367, File No. 333-183329, and File No. 333-198119), and Forms S-3 (File No. 333-170945, File No. 333-190996, and File No. 333-193699).
/s/ Grant Thornton LLP
Miami, Florida
March 15, 2016